Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats

Keyphrases

• Tempol 100%
• Streptozotocin-induced Diabetic Rats 100%
• In Vivo Applications 100%
• Renal Protection 100%
• Diabetic Rats 40%
• TRPC6 30%
• Transforming Growth Factor-β 30%
• Kidney 20%
• MRNA Level 20%
• Glutathione Peroxidase (GSH-Px) 20%
• Superoxide Dismutase 20%
• Protective Effect 10%
• MRNA Expression 10%
• Expression Level 10%
• Diabetes 10%
• Diabetic 10%
• Diabetic Kidney 10%
• Decreased Activity 10%
• Redox Status 10%
• Drinking Water 10%
• Albuminuria 10%
• Renal Function 10%
• Non-diabetic 10%
• Urine Output 10%
• Canonical Transient Receptor Potential 10%
• Malondialdehyde 10%
• Type IV Collagen 10%
• Chronic Treatment 10%
• Renal Tissue 10%
• Malondialdehyde Level 10%
• 24-hour Urine Collection 10%

Neuroscience

• In Vivo 100%
• Diabetes Mellitus 100%
• Streptozotocin 100%
• Tempol 100%
• TRPC6 30%
• Fibrinogen 30%
• Messenger RNA 30%
• Cancer Growth Factor 30%
• Superoxide Dismutase 20%
• Receptor Potential 10%
• Glutathione Peroxidase 10%
• Collagen Type 4 10%

Biochemistry, Genetics and Molecular Biology

• Streptozotocin 100%
• Rat 100%
• TRPC6 42%
• Fibrinogen 42%
• Cancer Growth Factor 42%
• mRNA Expression Level 28%
• Superoxide Dismutase 28%
• Receptor Potential 14%
• Glutathione Peroxidase 14%
• Kidney Function 14%
• Type IV Collagen 14%
• Messenger RNA 14%
• Expression Level 14%